Cargando…
Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
OBJECTIVE: To investigate the anti-anxiety activity of “6k”, a novel 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonist in in mice. MATERIALS AND METHODS: Anti-anxiety activity of “6k” (1, 2, and 4 mg/kg, intraperitoneally (i.p.)) was evaluated in mice by behavioral tests such as elevated plus...
Autores principales: | Kurhe, Yeshwant Vijay, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Gupta, Deepali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912791/ https://www.ncbi.nlm.nih.gov/pubmed/24550593 http://dx.doi.org/10.4103/0253-7613.125186 |
Ejemplares similares
-
Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014) -
Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015) -
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests
por: Bhatt, Shvetank, et al.
Publicado: (2013) -
Antidepressant Potential of 5-HT(3) Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)
por: Mahesh, R, et al.
Publicado: (2012) -
Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats
por: Gupta, Deepali, et al.
Publicado: (2013)